Recombinant Human Erythropoietin Therapy for Treatment of Anemia of Prematurity in Very Low Birth Weight Infants: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of Perinatology

Volumn 18, Issue 3, 1998, Pages 173-177

  Kumar, Praveen ^a,c   Shankaran, Seetha ^a,b   Krishnan, Ravi G ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; PLACEBO; RECOMBINANT PROTEIN;

ARTICLE; BLOOD; BLOOD CELL COUNT; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INFANT; LOW BIRTH WEIGHT; MALE; NEUTROPHIL; NEWBORN; NEWBORN ANEMIA; PATHOLOGY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT;

ANEMIA, NEONATAL; BLOOD CELL COUNT; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; FEMALE; FERRITINS; HUMANS; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NEUTROPHILS; PLACEBOS; RECOMBINANT PROTEINS; RETICULOCYTE COUNT;

EID: 0032062002     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Brown MS, Garcia JF, Phibbs RH, Dallman PR. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity. J Pediatr 1984;105:793-8.
2. Stockman JA III, Graeber JE, Clark DA, McCellan K, Garcia JF, Kavey RE. Anemia of prematurity: determinants of erythropoietin response. J Pediatr 1984;105:786-92.
3. Shannon KM, Naylor GS, Torkildson JC, Clemons GK, Schaffner V, Goldman SL, et al. Circulating erythroid progenitors in anemia of prematurity. N Engl J Med 1987;317:728-33.
4. Rhondeau SM, Christensen RD, Ross MP, Rothstein G, Simmons MA. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors in infants with the anemia of prematurity. J Pediatr 1988;112:935-40.
5. Halperin DS, Wacker P, Lacourt G, Felix M, Babel JF, Aapro M, et al. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr 1990;116:779-86.
6. Shannon KM, Mentzer WC, Abels RI, Freeman P, Newton N, Thompson D, et al. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr 1991;118:949-55.
7. Ohls RK, Christensen RD. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr 1991;119:781-8.
8. Stewart G, Holland BM, Turner TL, et al. Erythropoietin (rHuEPO) in preterm infants: does it work? [Abstract]. Br J Hematol 1991;77:4.
9. Shannon KM, Mentzer WC, Abels RI, Wertz M, Thayer-Moriyama J, Li WY, et al. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. J Pediatr 1992;120:586-92.
10. Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusion in preterm infants. J Pediatr 1992;121:98-102.
11. Messer J, Haddad J, Donato L, Astruc D, Malis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993;92:519-23.
12. Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity: results of a randomized controlled study. Pediatr Res 1993;34:675-9.
13. Maier RF, Oblanden M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, et al. The effect of epoietin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994;330:1173-8.
14. Meyer MP, Meyer JH, Commerford A, Hann FM, Sive AA, Moller G, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 1994;93:918-23.
15. Shannon KM, Keith JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1-8.
16. Emmerson AJB, Coles HJ, Stern CMM, Pearson TC. Erythropoietin in preterm infants. Arch Dis Child 1993;68.291-6.
17. Wilimas JA, Crist WA. Erythropoietin: not yet a standard treatment for anemia of prematurity. Pediatrics 1995;95:9-10.
18. Krishnan R, Shankaran S, Krishnan M, Kauffman RE, Kumar P, Lucena J, et al. Pharmacokinetics of eythropoietin following single-dose subcutaneous administration in preterm infants. Biol Neonate 1996;70:135-40.
19. Kivivuori SM, Heikinheimo M, Teppo AM, Siimes MA. Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very-low-birth-weight infants. Pediatr Res 1994;36:85-9.
20. Bader D, Blondheim O, Jonas R, Admoni O, Abend-Winger M, Reich D, et al. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity. Acta Paediatr 1996; 85:496-501.
21. Meyer MP, Haworth C, Meyer JH, Commerford A. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr 1996;129:258-63.
22. Mizuno S, Sasaki J, Suzuki C, Kono H, Kojima S. Effect of recombinant human erythropoietin administration on peripheral blood neutrophil counts of premature infants. J Pediatr 1994;124:467-70.